Product Information
MEXILETINE 150 MG CAPSULE is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.2266 per EA under NDC 64980066601. Its NADAC has been published 52 times since Aug 27, 2025.
FDA first approved this application on Aug 26, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
150 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
64980066601
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
MEXILETINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA215315FDA Approved
8/26/2022
TE Code
AB
On Market Since
2/5/2025
Pharmacological Classes
Price Statistics
The NADAC for MEXILETINE 150 MG CAPSULE has been published 52 times since Aug 27, 2025, and over the history we have for it it has declined 16.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2266 per EA |
|---|---|
| All-time high | $0.2727 (Sep 10, 2025) |
| All-time low | $0.2266 (Aug 19, 2026) |
| 52-week high | $0.2727 |
| 52-week low | $0.2266 |
| Median price | $0.2450 |
| Average price | $0.2461 |
| Largest weekly change | -7.7% (Oct 22, 2025) |
| Weeks tracked | 52 |
| Tracking since | Aug 27, 2025 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of MEXILETINE 150 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for MEXILETINE 150 MG CAPSULE, manufactured by Rising Pharma Holdings Inc., is $0.2266 per EA (NDC 64980066601), effective Aug 19, 2026.
How has the price of MEXILETINE 150 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for MEXILETINE 150 MG CAPSULE has declined 16.9%. It has been tracked across 52 weekly CMS publications since Aug 27, 2025.
What are the highest and lowest recorded NADAC prices for MEXILETINE 150 MG CAPSULE?
Since Aug 27, 2025, the NADAC for MEXILETINE 150 MG CAPSULE has ranged from a low of $0.2266 (Aug 19, 2026) to a high of $0.2727 (Sep 10, 2025), with a median of $0.2450 per EA.
Are there cheaper alternatives to MEXILETINE 150 MG CAPSULE?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as MEXILETINE 150 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures MEXILETINE 150 MG CAPSULE?
MEXILETINE 150 MG CAPSULE (NDC 64980066601) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.